Category-wise Analysis Product Type Insights Reduced glutathione is the leading product segment, holding approximately 62% of the market revenue share in 2025, as a result of several critical advantages tied directly to its biological activity and consumer acceptance
The FSP1-CoQ10-NAD(P)H pathway functions as an independent parallel system, synergising with GPX4 and GSH to inhibit lipid peroxidation and ferroptosis [44]
Preclinical studies do not indicate direct or indirect harmful effects regarding pregnancy, embryonic/embryonic development, childbirth or postnatal development
Still in its infancy, preclinical and clinical investigations have indicated that these therapies can change the course of diseases, relieve or ameliorate symptoms, or even change treatment response to a certain extent
Shotgun metagenomic sequencing identifies dysbiosis in triplet sibling with gastrointestinal symptoms and ASD